These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9591933)

  • 1. Pharmacokinetics and pharmacodynamics of acetazolamide in patients with transient intraocular pressure elevation.
    Yano I; Takayama A; Takano M; Inatani M; Tanihara H; Ogura Y; Honda Y; Inui K
    Eur J Clin Pharmacol; 1998 Mar; 54(1):63-8. PubMed ID: 9591933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equivalence of conventional and sustained release oral dosage formulations of acetazolamide in primary open angle glaucoma.
    Joyce PW; Mills KB; Richardson T; Mawer GE
    Br J Clin Pharmacol; 1989 May; 27(5):597-606. PubMed ID: 2757882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic Effect of Oral Acetazolamide against Intraocular Pressure Elevation after Cataract Surgery in Eyes with Glaucoma.
    Hayashi K; Yoshida M; Manabe SI; Yoshimura K
    Ophthalmology; 2017 May; 124(5):701-708. PubMed ID: 28110949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical 2.0% dorzolamide vs oral acetazolamide for prevention of intraocular pressure rise after neodymium:YAG laser posterior capsulotomy.
    Ladas ID; Baltatzis S; Panagiotidis D; Zafirakis P; Kokolakis SN; Theodossiadis GP
    Arch Ophthalmol; 1997 Oct; 115(10):1241-4. PubMed ID: 9338667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation.
    Rosenberg LF; Krupin T; Tang LQ; Hong PH; Ruderman JM
    Ophthalmology; 1998 Jan; 105(1):88-92; discussion 92-3. PubMed ID: 9442783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring acetazolamide treatment.
    Alm A; Berggren L; Hartvig P; Roosdorp M
    Acta Ophthalmol (Copenh); 1982 Feb; 60(1):24-34. PubMed ID: 6753451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetazolamide influences ocular pulse amplitude.
    Zinkernagel MS; Ebneter A
    J Ocul Pharmacol Ther; 2009 Apr; 25(2):141-4. PubMed ID: 19284322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive ocular hypotensive effect of latanoprost and acetazolamide. A short-term study in patients with elevated intraocular pressure.
    Rulo AH; Greve EL; Hoyng PF
    Ophthalmology; 1997 Sep; 104(9):1503-7. PubMed ID: 9307648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral acetazolamide for intraocular pressure lowering: balancing efficacy and safety in ophthalmic practice.
    Gulati S; Aref AA
    Expert Rev Clin Pharmacol; 2021 Aug; 14(8):955-961. PubMed ID: 34003717
    [No Abstract]   [Full Text] [Related]  

  • 10. Improvement of acetazolamide ocular permeation using ascorbyl laurate nanostructures as drug delivery system.
    Tártara LI; Quinteros DA; Saino V; Allemandi DA; Palma SD
    J Ocul Pharmacol Ther; 2012 Apr; 28(2):102-9. PubMed ID: 22060001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the effectiveness of dorzolamide and acetazolamide in preventing post-operative intraocular pressure rise following phacoemulsification surgery.
    Zohdy GA; Rogers ZA; Lukaris A; Sells M; Roberts-Harry TJ
    J R Coll Surg Edinb; 1998 Oct; 43(5):344-6. PubMed ID: 9803110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Pharmacokinetic Study Examining Acetazolamide as a Novel Adherence Marker for Clinical Trials.
    Hampson AJ; Babalonis S; Lofwall MR; Nuzzo PA; Krieter P; Walsh SL
    J Clin Psychopharmacol; 2016 Aug; 36(4):324-32. PubMed ID: 27300254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetic and pharmacodynamic modeling of acetazolamide in peritoneal dialysis patients and healthy volunteers.
    Yue CS; Huynh HH; Raymond C; Charbonneau L; Roy L
    J Pharm Pharm Sci; 2013; 16(1):89-98. PubMed ID: 23683608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of acetazolimide after intravenous and oral administration in horses.
    Alberts MK; Clarke CR; MacAllister CG; Homer LM
    Am J Vet Res; 2000 Aug; 61(8):965-8. PubMed ID: 10951991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraocular and intracranial pressure in glaucoma patients taking acetazolamide.
    Loiselle AR; de Kleine E; van Dijk P; Jansonius NM
    PLoS One; 2020; 15(6):e0234690. PubMed ID: 32555666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The additive effect of topical dorzolamide and systemic acetazolamide in pediatric glaucoma.
    Sabri K; Levin AV
    J AAPOS; 2006 Oct; 10(5):464-8. PubMed ID: 17070484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of topical carbonic anhydrase inhibitor (MK-507) on intraocular pressure of normal human eyes].
    Yamazaki Y; Miyamoto S; Sawa M
    Nippon Ganka Gakkai Zasshi; 1994 Mar; 98(3):293-7. PubMed ID: 8154389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical control of intraocular pressure after phacoemulsification.
    Dayanir V; Ozcura F; Kir E; Topaloğlu A; Ozkan SB; Aktunç T
    J Cataract Refract Surg; 2005 Mar; 31(3):484-8. PubMed ID: 15811735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term changes in intraocular pressure after phacoemulsification in glaucoma patients.
    Fogagnolo P; Centofanti M; Figus M; Frezzotti P; Fea A; Ligorio P; Lembo A; Digiuni M; Lorenzi U; Rossetti L
    Ophthalmologica; 2012; 228(3):154-8. PubMed ID: 22572718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of MK-507 on aqueous humor dynamics in normal human eyes.
    Yamazaki Y; Miyamoto S; Sawa M
    Jpn J Ophthalmol; 1994; 38(1):92-6. PubMed ID: 7933704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.